Intra-Articular Delivery of Sustained Release NF-kB Antagonists in Arthritis
关节内缓释 NF-kB 拮抗剂治疗关节炎
基本信息
- 批准号:10092120
- 负责人:
- 金额:$ 32.75万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2017
- 资助国家:美国
- 起止时间:2017-02-01 至 2023-01-31
- 项目状态:已结题
- 来源:
- 关键词:AcuteAffectAfferent NeuronsAnkleArthritisAttenuatedBehavioralCatabolismCell DeathChronicClinicalCollaborationsControl GroupsDegenerative polyarthritisDevelopmentDrug Delivery SystemsEtiologyExtracellular MatrixFibroinsFormulationFractureFunctional disorderGaitGene ActivationGenesHip region structureHistologyHydrophobicityI Kappa B-AlphaImageImmunohistochemistryIn VitroInflammationInflammatoryInjuryIntra-Articular InjectionsJointsKneeLuciferasesMeasuresMechanicsMicrospheresModelingMonitorMusMusculoskeletalNF-kappa BNF-kappaB-inducing kinaseNerve Growth FactorsNociceptionOutcomeOutcome MeasurePainPathogenesisPathologyPatientsPatternPharmaceutical PreparationsPharmacologyRecording of previous eventsReporterRoleSilkSpinal GangliaSubstance PSymptomsSynovitisTestingTherapeuticTibial FracturesTimeTissuesTraumaUniversitiesWeight-Bearing stateWorkaqueousbasecytokinedisabilitydrug testingimprovedin vivoinhibitor/antagonistjoint destructionjoint functionjoint inflammationjoint injurylimb injuryluminescencelymph nodesmolecular markermouse modelphysical propertyprematureresidencesmall moleculesymptom treatmenttranscription factortreatment strategy
项目摘要
Injury or trauma to the knee, hip, or ankle is a well-documented contributor to premature onset of joint
degeneration and osteoarthritis (OA). Nuclear factor kappa B (NF-B) is a transcription factor that has early
involvement in post-traumatic OA by activating genes involved in extracellular matrix catabolism and joint
inflammation. Increased NF-B activity has also been implicated in the development of pain following joint injury
and other musculoskeletal pathologies. Despite the availability of numerous compounds that inhibit NF-B,
pharmacologic inhibition of NF-B via systemic administration or even local delivery to the joint has not been
successful in the treatment of OA. We hypothesize that intra-articular delivery of NF-B antagonists from
a safe, sustained-release carrier (silk) will have value in attenuating pain related sensitivities, joint
dysfunction, and progressive joint pathology in a non-surgical, intra-articular fracture model of OA. We
have previously identified a strong correlation between NF-B activity and pain-related sensitivity in a model of
inflammatory joint injury using the NF-B-luciferase reporter mouse. Here, we will similarly track NF-B activity,
but in a mouse model of closed tibial fracture as a non-surgical model of joint injury which is known to progress
to OA. In Specific Aim 1, we will evaluate the temporal and spatial development of NF-B activity, pain-
related sensitivities, and joint dysfunction in mice following intra-articular fracture out to 8 weeks. We will
identify relationships between systemic and local NF-B activation, patterns for sensitivity, gait and weight-
bearing, and arthritis progression following joint fracture. Results will identify “therapeutic windows” for timing of
intra-articular drug delivery in Specific Aim 3. In Specific Aim 2, we will optimize silk fibroin microparticle
depots for sustained release of two small molecule NF-B inhibitors, SC-514 or PHA-408. We have
previously demonstrated increased residence times for silk fibroin microparticles when delivered to the joint
space, but have not incorporated a drug for sustained release. Silk fibroin microparticles (10-60 microns) will be
fabricated specific to each NF-B inhibitor, and tested to verify high drug loading and sustained release out to 4
weeks. In Specific Aim 3, we will evaluate if a single, intra-articular injection of SC-514 or PHA-408-loaded
silk fibroin microparticles can attenuate NF-B activation, pain-related sensitivities, joint dysfunction,
and joint pathology after intra-articular fracture. Intra-articular injections of drug-loaded microparticles will
be administered to the injured limb at either early or late times after injury, with longitudinal monitoring of effects
on NF-B activation, pain-related sensitivities, joint dysfunction and arthritis development. Results will reveal
whether either compound, and at which time, can modulate defined outcome measures of arthritis symptoms
and/or pathology progression in this model of OA. This work will establish a safe, sustained release strategy
for the local treatment of OA that can advance utility for an entire class of small molecule NF-B
antagonists with a high likelihood for treating pathology and/or pain development in patients with OA.
膝关节、髋关节或踝关节的损伤或创伤是关节炎过早发作的一个有据可查的因素。
退行性变和骨关节炎(OA)。核因子κ B(NF-κ B B)是一种转录因子,
通过激活参与细胞外基质软骨和关节的基因参与创伤后OA
炎症增加的NF-κ B B活性也与关节损伤后疼痛的发展有关
和其他肌肉骨骼疾病。尽管有许多抑制NF-κ B B的化合物,
通过全身给药或甚至局部递送至关节的NF-κ B B的药理学抑制尚未被
成功治疗OA。我们假设,关节内注射NF-κ B B拮抗剂,
安全、缓释的载体(丝绸)将在减轻与疼痛相关的敏感性、关节方面具有价值
功能障碍和进行性关节病理学。我们
先前已经在一个模型中确定了NF-κ B B活性和疼痛相关敏感性之间的强相关性,
使用NF-κ B-荧光素酶报告小鼠观察炎性关节损伤。在这里,我们将类似地跟踪NF-κ B B活性,
但在小鼠闭合性胫骨骨折模型中,作为关节损伤的非手术模型,
到OA。在具体目标1中,我们将评估NF-κ B B活性、疼痛和神经功能的时间和空间发展。
相关的敏感性,和关节功能障碍的小鼠关节内骨折后8周。我们将
确定全身和局部NF-κ B B激活、敏感性模式、步态和体重之间的关系,
关节骨折后关节炎进展。结果将确定“治疗窗口”,
Specific Aim 3中的关节内药物递送。在具体目标2中,我们将优化丝素蛋白微粒
用于持续释放两种小分子NF-κ B B抑制剂SC-514或PHA-408的贮库。我们有
先前证明丝纤蛋白微粒在递送至关节时的停留时间增加
空间,但没有纳入持续释放的药物。丝纤蛋白微粒(10-60微米)将被
制造的特定于每一种NF-κ B B抑制剂,并进行测试,以验证高载药量和持续释放到4
周在特定目标3中,我们将评估单次关节内注射SC-514或PHA-408载药
丝纤蛋白微粒可减弱NF-κ B B活化、疼痛相关敏感性、关节功能障碍
和关节内骨折后的关节病理学。关节内注射载药微粒将
在受伤后的早期或晚期给予受伤肢体,并纵向监测效果
对NF-κ B B活化、疼痛相关敏感性、关节功能障碍和关节炎发展的影响。结果将揭示
无论是哪种化合物,以及在什么时候,可以调节关节炎症状的定义结果测量
和/或病理学进展。这项工作将建立一个安全,持续释放策略
对于OA的局部治疗,可以提高整个类别的小分子NF-κ B B的效用
具有治疗OA患者的病理学和/或疼痛发展的高可能性的拮抗剂。
项目成果
期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Intraarticularly injectable silk hydrogel microspheres with enhanced mechanical and structural stability to attenuate osteoarthritis.
- DOI:10.1016/j.biomaterials.2022.121611
- 发表时间:2022-05
- 期刊:
- 影响因子:14
- 作者:Tao Wang;Yuqi Li;Jian Liu;Y. Fang;Wen-jun Guo;Yu Liu;Xiangyu Li;Gang Li;Xiuli Wang
- 通讯作者:Tao Wang;Yuqi Li;Jian Liu;Y. Fang;Wen-jun Guo;Yu Liu;Xiangyu Li;Gang Li;Xiuli Wang
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Lori A. Setton其他文献
Evaluierung von Knorpelmarkern nach Meniskektomie im longitudinalen Verlauf
纵向评估
- DOI:
- 发表时间:
1997 - 期刊:
- 影响因子:0
- 作者:
E. Lindhorst;Thomas P. Vail;Farshid Guilak;Lori A. Setton;Sean P. Scully;V. Byers;L. Gotzen - 通讯作者:
L. Gotzen
Chapter 62: TISSUE ENGINEERING FOR REGENERATION AND REPLACEMENT OF THE INTERVERTEBRAL DISC (In press, Principles of Tissue Engineering, (eds) RP Lanza, R Langer and J Vacanti. Academic Press, 4 th edition)
第 62 章:椎间盘再生和替换的组织工程(出版中,《组织工程原理》,(编辑)RP Lanza、R Langer 和 J Vacanti。学术出版社,第 4 版)
- DOI:
- 发表时间:
2006 - 期刊:
- 影响因子:0
- 作者:
Lori A. Setton;Lawrence Bonassar;Koichi Masuda - 通讯作者:
Koichi Masuda
A genetically engineered thermally responsive sustained release curcumin depot to treat neuroinflammation
- DOI:
10.1016/j.jconrel.2013.06.032 - 发表时间:
2013-10-10 - 期刊:
- 影响因子:
- 作者:
S. Michael Sinclair;Jayanta Bhattacharyya;Jonathan R. McDaniel;David M. Gooden;Ramesh Gopalaswamy;Ashutosh Chilkoti;Lori A. Setton - 通讯作者:
Lori A. Setton
Correction to: Size-Dependent Effective Diffusivity in Healthy Human and Porcine Joint Synovium
- DOI:
10.1007/s10439-022-02939-8 - 发表时间:
2022-02-27 - 期刊:
- 影响因子:5.400
- 作者:
Young Guang;Alexandra L. Davis;Thomas M. McGrath;Christine T. N. Pham;James A. J. Fitzpatrick;Lori A. Setton - 通讯作者:
Lori A. Setton
System zur direkten heilmittelverabreichung auf der basis wärmegesteuerter biopolymere
生物聚合物基础系统
- DOI:
- 发表时间:
2006 - 期刊:
- 影响因子:0
- 作者:
Lori A. Setton;Ashutosh Chilkoti;Virginia B Kraus;Helawe Betre;M. Dreher - 通讯作者:
M. Dreher
Lori A. Setton的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Lori A. Setton', 18)}}的其他基金
Intervertebral Disc Degeneration and Cross-Talk with the Nervous System
椎间盘退变和与神经系统的交互作用
- 批准号:
10412615 - 财政年份:2020
- 资助金额:
$ 32.75万 - 项目类别:
Intervertebral Disc Degeneration and Cross-Talk with the Nervous System
椎间盘退变和与神经系统的交互作用
- 批准号:
10672264 - 财政年份:2020
- 资助金额:
$ 32.75万 - 项目类别:
Intervertebral Disc Degeneration and Cross-Talk with the Nervous System
椎间盘退变和与神经系统的交互作用
- 批准号:
10454431 - 财政年份:2020
- 资助金额:
$ 32.75万 - 项目类别:
Intervertebral Disc Degeneration and Cross-Talk with the Nervous System
椎间盘退变和与神经系统的交互作用
- 批准号:
10031377 - 财政年份:2020
- 资助金额:
$ 32.75万 - 项目类别:
Intervertebral Disc Degeneration and Cross-Talk with the Nervous System
椎间盘退变和与神经系统的交互作用
- 批准号:
10652003 - 财政年份:2020
- 资助金额:
$ 32.75万 - 项目类别:
Intervertebral Disc Degeneration and Cross-Talk with the Nervous System
椎间盘退变和与神经系统的交互作用
- 批准号:
10225556 - 财政年份:2020
- 资助金额:
$ 32.75万 - 项目类别:
Intervertebral Disc Degeneration and Cross-Talk with the Nervous System
椎间盘退变和与神经系统的交互作用
- 批准号:
10897489 - 财政年份:2020
- 资助金额:
$ 32.75万 - 项目类别:
Biomedical Engineering Society 2017 Annual Meeting
生物医学工程学会2017年年会
- 批准号:
9398340 - 财政年份:2017
- 资助金额:
$ 32.75万 - 项目类别:
Engineering Microenvironments for the Nucleus Pulposus Cell
髓核细胞的工程微环境
- 批准号:
9228325 - 财政年份:2016
- 资助金额:
$ 32.75万 - 项目类别:
CELLULAR DELIVERY OF RAT INTERVERTEBRAL DISC CELLS IN DISC DEGENERATION MODEL
椎间盘退变模型中大鼠椎间盘细胞的细胞递送
- 批准号:
8363214 - 财政年份:2011
- 资助金额:
$ 32.75万 - 项目类别:
相似海外基金
RII Track-4:NSF: From the Ground Up to the Air Above Coastal Dunes: How Groundwater and Evaporation Affect the Mechanism of Wind Erosion
RII Track-4:NSF:从地面到沿海沙丘上方的空气:地下水和蒸发如何影响风蚀机制
- 批准号:
2327346 - 财政年份:2024
- 资助金额:
$ 32.75万 - 项目类别:
Standard Grant
BRC-BIO: Establishing Astrangia poculata as a study system to understand how multi-partner symbiotic interactions affect pathogen response in cnidarians
BRC-BIO:建立 Astrangia poculata 作为研究系统,以了解多伙伴共生相互作用如何影响刺胞动物的病原体反应
- 批准号:
2312555 - 财政年份:2024
- 资助金额:
$ 32.75万 - 项目类别:
Standard Grant
How Does Particle Material Properties Insoluble and Partially Soluble Affect Sensory Perception Of Fat based Products
不溶性和部分可溶的颗粒材料特性如何影响脂肪基产品的感官知觉
- 批准号:
BB/Z514391/1 - 财政年份:2024
- 资助金额:
$ 32.75万 - 项目类别:
Training Grant
Graduating in Austerity: Do Welfare Cuts Affect the Career Path of University Students?
紧缩毕业:福利削减会影响大学生的职业道路吗?
- 批准号:
ES/Z502595/1 - 财政年份:2024
- 资助金额:
$ 32.75万 - 项目类别:
Fellowship
感性個人差指標 Affect-X の構築とビスポークAIサービスの基盤確立
建立个人敏感度指数 Affect-X 并为定制人工智能服务奠定基础
- 批准号:
23K24936 - 财政年份:2024
- 资助金额:
$ 32.75万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Insecure lives and the policy disconnect: How multiple insecurities affect Levelling Up and what joined-up policy can do to help
不安全的生活和政策脱节:多种不安全因素如何影响升级以及联合政策可以提供哪些帮助
- 批准号:
ES/Z000149/1 - 财政年份:2024
- 资助金额:
$ 32.75万 - 项目类别:
Research Grant
How does metal binding affect the function of proteins targeted by a devastating pathogen of cereal crops?
金属结合如何影响谷类作物毁灭性病原体靶向的蛋白质的功能?
- 批准号:
2901648 - 财政年份:2024
- 资助金额:
$ 32.75万 - 项目类别:
Studentship
ERI: Developing a Trust-supporting Design Framework with Affect for Human-AI Collaboration
ERI:开发一个支持信任的设计框架,影响人类与人工智能的协作
- 批准号:
2301846 - 财政年份:2023
- 资助金额:
$ 32.75万 - 项目类别:
Standard Grant
Investigating how double-negative T cells affect anti-leukemic and GvHD-inducing activities of conventional T cells
研究双阴性 T 细胞如何影响传统 T 细胞的抗白血病和 GvHD 诱导活性
- 批准号:
488039 - 财政年份:2023
- 资助金额:
$ 32.75万 - 项目类别:
Operating Grants
How motor impairments due to neurodegenerative diseases affect masticatory movements
神经退行性疾病引起的运动障碍如何影响咀嚼运动
- 批准号:
23K16076 - 财政年份:2023
- 资助金额:
$ 32.75万 - 项目类别:
Grant-in-Aid for Early-Career Scientists